IRIS

Treatment with intravenous High Dose Interferon (HDI) is able to reduce levels of circulating regulatory T (Treg) cells in melanoma patients / Ascierto, P; Gentilcore, G; Napolitano, M; Simeone, E; Capone, M; Daponte, A; Palmieri, G; Castello, G; Celentano, E; Mozzillo, N. - In: EUROPEAN JOURNAL OF CANCER. SUPPLEMENT. - ISSN 1359-6349. - 7:2(2009), pp. 583-583.

Treatment with intravenous High Dose Interferon (HDI) is able to reduce levels of circulating regulatory T (Treg) cells in melanoma patients

Ascierto P;
2009
2009
Treatment with intravenous High Dose Interferon (HDI) is able to reduce levels of circulating regulatory T (Treg) cells in melanoma patients / Ascierto, P; Gentilcore, G; Napolitano, M; Simeone, E; Capone, M; Daponte, A; Palmieri, G; Castello, G; Celentano, E; Mozzillo, N. - In: EUROPEAN JOURNAL OF CANCER. SUPPLEMENT. - ISSN 1359-6349. - 7:2(2009), pp. 583-583.
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014373
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact